SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-029051
Filing Date
2021-05-25
Accepted
2021-05-25 16:09:17
Documents
6
Period of Report
2021-05-19
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea141620-8k_aditxtherap.htm 8-K 41551
2 CERTIFICATE OF AMENDMENT, FILED WITH THE SECRETARY OF STATE OF THE STATE OF DELA ea141620ex3-1_aditxtherap.htm EX-3.1 1771
3 SHAREHOLDERS LETTER, DATED MAY 24, 2021 ea141620ex99-1_aditxtherap.htm EX-99.1 18976
4 GRAPHIC ex99-1_001.jpg GRAPHIC 11945
5 GRAPHIC ex3-1_001.jpg GRAPHIC 101078
6 GRAPHIC ex3-1_002.jpg GRAPHIC 198066
  Complete submission text file 0001213900-21-029051.txt   492176
Mailing Address 2569 WYANDOTTE, ST. SUITE 101 MOUNTAIN CA 94043
Business Address 2569 WYANDOTTE, ST. SUITE 101 MOUNTAIN CA 94043 909-488-0844
Aditx Therapeutics, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 21960688
SIC: 2834 Pharmaceutical Preparations